1. Home
  2. BIO vs UMBF Comparison

BIO vs UMBF Comparison

Compare BIO & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$304.33

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo UMB Financial Corporation

UMBF

UMB Financial Corporation

HOLD

Current Price

$118.54

Market Cap

8.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
UMBF
Founded
1952
1913
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Major Banks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIO
UMBF
Price
$304.33
$118.54
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$358.50
$136.27
AVG Volume (30 Days)
158.4K
436.7K
Earning Date
10-29-2025
01-27-2026
Dividend Yield
N/A
1.46%
EPS Growth
N/A
10.98
EPS
N/A
8.89
Revenue
$2,557,500,000.00
$2,217,071,000.00
Revenue This Year
$1.77
$69.52
Revenue Next Year
$2.30
$7.83
P/E Ratio
N/A
$13.29
Revenue Growth
N/A
45.52
52 Week Low
$211.43
$82.00
52 Week High
$373.69
$126.14

Technical Indicators

Market Signals
Indicator
BIO
UMBF
Relative Strength Index (RSI) 42.52 63.52
Support Level $307.08 $117.05
Resistance Level $319.50 $120.58
Average True Range (ATR) 8.41 2.93
MACD -1.74 0.88
Stochastic Oscillator 10.83 79.95

Price Performance

Historical Comparison
BIO
UMBF

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.

Share on Social Networks: